Does DABRAFENIB Cause Metastases to bone marrow? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Metastases to bone marrow have been filed in association with DABRAFENIB (Tafinlar). This represents 0.0% of all adverse event reports for DABRAFENIB.
8
Reports of Metastases to bone marrow with DABRAFENIB
0.0%
of all DABRAFENIB reports
5
Deaths
6
Hospitalizations
How Dangerous Is Metastases to bone marrow From DABRAFENIB?
Of the 8 reports, 5 (62.5%) resulted in death, 6 (75.0%) required hospitalization, and 1 (12.5%) were considered life-threatening.
Is Metastases to bone marrow Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DABRAFENIB. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does DABRAFENIB Cause?
Pyrexia (3,788)
Death (2,740)
Malignant neoplasm progression (1,667)
Fatigue (1,328)
Nausea (1,300)
Chills (1,235)
Rash (1,078)
Vomiting (907)
Diarrhoea (901)
Headache (697)
What Other Drugs Cause Metastases to bone marrow?
CYCLOPHOSPHAMIDE (65)
DOXORUBICIN (40)
CYTARABINE (36)
CARBOPLATIN (35)
ZOLEDRONIC ACID (32)
ETOPOSIDE (31)
OXALIPLATIN (30)
RIBOCICLIB (29)
RITUXIMAB (29)
VINCRISTINE (28)
Which DABRAFENIB Alternatives Have Lower Metastases to bone marrow Risk?
DABRAFENIB vs DABRAFENIB\TRAMETINIB
DABRAFENIB vs DACARBAZINE
DABRAFENIB vs DACLATASVIR
DABRAFENIB vs DACLIZUMAB
DABRAFENIB vs DACOMITINIB